JFG
NVCR icon

Jefferies Financial Group’s NovoCure NVCR Stock Holding History

Jefferies Financial Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,310
Closed -$396K – 1746
2024
Q1 		$396K Buy
+25,310
New +$372K ﹤0.01% 1124
2023
Q4 		– Sell
-492,790
Closed -$7.96M – 1902
2023
Q3 		$7.96M Buy
+492,790
New +$14.2M 0.07% 214

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jefferies Financial Group's NVCR Position: Q2 2024 in Review

Jefferies Financial Group sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 25,310 shares — an estimated $396K sold.

Jefferies Financial Group first reported a position in NVCR in Q3 2023 and held it in 2 quarters. The position peaked at $7.96M in Q3 2023. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • Jefferies Financial Group reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 25,310 NovoCure shares in Q2 2024, an estimated $396K.
  • Jefferies Financial Group first reported a position in NovoCure in Q3 2023 and held it in 2 quarters.
  • Jefferies Financial Group's NovoCure position peaked at $7.96M in Q3 2023.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.